Note that some devices like dulaglutide have fixed needles
Many patients find that non-oral methods also reduce overall pill burden during weight loss treatment
The main benefits of GLP-1 therapy include: Enhanced insulin secretion in response to meals Reduced glucagon release, preventing high blood sugar levels Slowed gastric emptying, leading to prolonged satiety Decreased appetite, which may help with weight loss Currently available GLP-1 receptor agonists include drugs like liraglutide (Victoza), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
Market Dynamics The United States remains the dominant force in the obesity therapeutics market, accounting for approximately half of global revenue
What Do Clinical Studies And Safety Reviews Say So Far
doi:10.1177/107327480501200403